Solicitation of Nominations for Appointment to CDC's Advisory Committee to the Director Data and Surveillance Workgroup, 49464-49465 [2023-16102]
Download as PDF
<![CDATA[
49464
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
Matters to be Considered: The open
session of the meeting will include a
discussion on the updated Intimate
Partner Violence Prevention Research
Priorities. The closed session of the
meeting will focus on the Secondary
Peer Review of extramural research
grant applications received in response
to one (1) Notice of Funding
Opportunity: RFA–CE–24–001—‘‘Grants
for Injury Control Research Centers.’’
Agenda items are subject to change as
priorities dictate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16104 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Solicitation of Nominations for
Appointment to CDC’s Advisory
Committee to the Director Data and
Surveillance Workgroup
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), within
the Department of Health and Human
Services (HHS), is seeking nominations
for membership on the Advisory
Committee to the Director Data and
Surveillance Workgroup (DSW). The
DSW consists of approximately 15
members who are experts in fields
associated with public health science
and practice; policy development,
analysis, and implementation; and
surveillance and informatics.
DATES: Nominations for membership on
the DSW must be received no later than
August 30, 2023. Late nominations will
not be considered for membership.
ADDRESSES: All nominations (cover
letters and curriculum vitae) should be
emailed to DSWACD@cdc.gov with the
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
subject line: ‘‘Nomination for CDC ACD
DSW Workgroup.’’
FOR FURTHER INFORMATION CONTACT:
Agnes Warner, MPA, Office of Public
Health Data, Surveillance, and
Technology, Centers for Disease Control
and Prevention, 1600 Clifton Road NE,
Mailstop H21–10, Atlanta, Georgia
30329–4027. Telephone: (404) 639–
3372; Email: DSWACD@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The purpose of the
Advisory Committee to the Director,
Centers for Disease Control and
Prevention (ACD, CDC) is to (1) make
recommendations to the Director
regarding ways to prioritize the
activities of the agency in alignment
with the CDC Strategic Plan required
under section 305(c); H.R. 2617–1252;
(2) advise on ways to achieve or
improve performance metrics in relation
to the CDC Strategic Plan, and other
relevant metrics, as appropriate; (3)
provide advice and recommendations
on the development of the Strategic
Plan, and any subsequent updates, as
appropriate; (4) advise on grants,
cooperative agreements, contracts, or
other transactions, as applicable; (5)
provide other advice to the Director, as
requested, to fulfill duties under
sections 301 and 311; and (6) appoint
subcommittees. The ACD, CDC consists
of up to 15 non-federal members,
including the Chair, knowledgeable in
areas pertinent to the CDC mission, such
as health policy, public health, global
health, preparedness, preventive
medicine, the faith-based and
community-based sector, and allied
fields.
Purpose: The purpose of the ACD,
CDC Data and Surveillance Workgroup
(DSW) is to provide input to the
Committee on agency-wide activities
related to the scope and implementation
of CDC’s data modernization strategy
across the agency, ultimately playing a
key role in the agency’s work with
public health, healthcare, and academic
and private sector partners and with the
promotion of equity. The DSW
membership consists of approximately
15 members. It is co-chaired by two
current ACD, CDC Special Government
Employees. The DSW co-chairs will
present their findings, observations, and
work products at one or more ACD, CDC
meetings for discussion, deliberation,
and decisions (final recommendations
to CDC).
Nomination Criteria: DSW members
will serve terms ranging from six
months to one year and be required to
attend DSW meetings approximately 1–
2 times per month (virtually or in
person), and contribute time in between
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
meetings for research, consultation,
discussion, and writing assignments.
Nominations are being sought for
individuals who have the expertise and
qualifications necessary to contribute to
the accomplishments of the
committee’s/workgroup’s objectives.
Nominees will be selected based on
expertise in the fields of public health
science and practice; public health
preparedness and response; public
health policy development, analysis,
and implementation; public health
surveillance and informatics; artificial
intelligence; data analysis, data science,
and forecasting; health information
technology; and healthcare delivery
from jurisdictional government
agencies, non-government
organizations, academia, and the private
sector. To ensure a diverse workgroup
composition, nominees with front line
and field experience at the local, state,
tribal, and territorial levels are
encouraged to apply. This includes
nominees with experience working for,
and with, community-based
organizations and other non-profit
organizations. Federal employees will
not be considered for membership.
Selection of members is based on
candidates’ qualifications to contribute
to the accomplishment of the DSW’s
objectives.
HHS policy stipulates that
membership be balanced in terms of
points of view represented and the
workgroup’s function. Appointments
shall be made without discrimination
based on age, race, ethnicity, gender,
sexual orientation, gender identity, HIV
status, disability, and cultural, religious,
or socioeconomic status. Nominees
must be U.S. citizens. Current
participation on federal workgroups or
prior experience serving on a federal
advisory committee does not disqualify
a candidate; however, HHS policy is to
avoid excessive individual service on
advisory committees and multiple
committee memberships. Interested
candidates should submit the following
items:
D A one-half to one-page cover letter
that includes your understanding of,
and commitment to, the time and work
necessary; one to two sentences on your
background and experience; and one to
two sentences on the skills/perspective
you would bring to the DSW.
D Current curriculum vitae which
highlights the experience and work
history being sought relevant to the
criteria set forth above, including
complete contact information
(telephone numbers, mailing address,
email address).
E:\FR\FM\31JYN1.SGM
31JYN1
Federal Register / Vol. 88, No. 145 / Monday, July 31, 2023 / Notices
Nominations may be submitted by the
candidate or by the person/organization
recommending the candidate.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–16102 Filed 7–28–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
National Center for Health Statistics,
ICD–10 Coordination and Maintenance
Committee
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
The Centers for Disease
Control and Prevention (CDC), National
Center for Health Statistics (NCHS),
Classifications and Public Health Data
Standards Staff, announces the
following meeting of the ICD–10
Coordination and Maintenance (C&M)
Committee. This meeting is open to the
public, limited only by the number of
audio lines available. Online
Registration is required.
DATES: The meeting will be held on
September 12, 2023, from 9 a.m. to 5
p.m., EDT, and September 13, 2023,
from 9 a.m. to 5 p.m., EDT.
ADDRESSES: This is a virtual meeting.
Register in advance at https://
cms.zoomgov.com/webinar/register/
WN_lWLKuwKzQU6iJdvcDvXhdA. After
registering, you will receive a
confirmation email containing
information about joining the meeting.
Further information will be provided on
each of the respective web pages when
it becomes available. For CDC, NCHS:
https://www.cdc.gov/nchs/icd/icd10cm_
maintenance.htm. For the Centers for
Medicare & Medicaid Services,
Department of Health and Human
Services: https://www.cms.gov/
Medicare/Coding/ICD10/C-and-MMeeting-Materials.
ddrumheller on DSK120RN23PROD with NOTICES1
SUMMARY:
VerDate Sep<11>2014
18:11 Jul 28, 2023
Jkt 259001
FOR FURTHER INFORMATION CONTACT:
Traci Ramirez, Medical Classification
Specialist, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 3311 Toledo Road,
Hyattsville, Maryland 20782–2064.
Telephone: (301) 458–4454; Email:
TRamirez@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The ICD–10 Coordination
and Maintenance (C&M) Committee is a
public forum for the presentation of
proposed modifications to the
International Classification of Diseases,
Tenth Revision, Clinical Modification
(CM) and ICD–10 Procedure Coding
System (PCS).
Matters to be Considered: The
tentative agenda will include
discussions on the ICD–10–CM and
ICD–10–PCS topics listed below.
Agenda items are subject to change as
priorities dictate. Please refer to the
posted agenda for updates one month
prior to the meeting.
ICD–10–PCS Topics:
1. Administration of Iodine (131I)
Apamistamab **
2. Irreversible Electroporation for
Cardiac Ablation **
3. Computer-aided Anesthesia and
Oxygen Delivery System ***
4. Sub-epidermal Moisture Sensor **
5. Insertion of Palladium-103
Radioactive Implant *
6. Implantation of Bone Void Filler ***
7. Section X Updates
8. Addenda and Key Updates *
* Request is for an April 1, 2024,
implementation date.
** Request is for an April 1, 2024,
implementation date, and the requestor
intends to submit a new technology
add-on payment (NTAP) application for
FY 2025 consideration.
*** Requestor intends to submit an
NTAP application for FY 2025
consideration.
Presentations for procedure code
requests are conducted by both the
requestor and the Centers for Medicare
& Medicaid Services (CMS) during the
C&M Committee meeting. Discussion
from the requestor generally focuses on
the clinical issues for the procedure or
technology, followed by the proposed
coding options from a CMS analyst.
Topics presented may also include
requests for new procedure codes that
relate to a new technology add-on
payment (NTAP) policy request.
CMS has modified the approach for
presenting the new NTAP-related ICD–
10–PCS procedure code requests that
involve the administration of a
therapeutic agent. For the September
12–13, 2023, ICD–10 C&M Committee
meeting, consistent with the
PO 00000
Frm 00032
Fmt 4703
Sfmt 4703
49465
requirements of section
1886(d)(5)(K)(iii) of the Social Security
Act, applicants submitted requests to
create a unique procedure code to
describe the administration of a
therapeutic agent, such as the option to
create a new code in Section X within
the ICD–10–PCS procedure code
classification. CMS will initially display
only those meeting materials associated
with the NTAP-related ICD–10–PCS
procedure code requests that involve the
administration of a therapeutic agent on
the CMS website in August 2023 at:
https://www.cms.gov/Medicare/Coding/
ICD10/C-and-M-Meeting-Materials.
The NTAP-related ICD–10–PCS
procedure code request that involves the
administration of a therapeutic agent is:
Administration of Iodine (131I)
Apamistamab **
** Request is for an April 1, 2024,
implementation date, and the requestor
intends to submit an NTAP application
for FY 2025 consideration.
This topic will not be presented
during the September 12–13, 2023,
meeting. CMS will solicit public
comments regarding any clinical
questions or coding options included for
this procedure code topic in advance of
the meeting continuing through the end
of the respective public comment
periods. Members of the public should
send any questions or comments to the
CMS mailbox at:
ICDProcedureCodeRequest@
cms.hhs.gov.
CMS intends to post a question-andanswer document in advance of the
meeting to address any clinical or
coding questions that members of the
public may have submitted. Following
the conclusion of the meeting, CMS will
post an updated question-and-answer
document to address any additional
clinical or coding questions that
members of the public may have
submitted during the meeting that CMS
was not able to address or that were
submitted after the meeting.
The NTAP-related ICD–10–PCS
procedure code requests that do not
involve the administration of a
therapeutic agent and all non-NTAPrelated procedure code requests will
continue to be presented during the
virtual meeting on September 12, 2023,
consistent with the standard meeting
process.
CMS will make all meeting materials
and related documents available at:
https://www.cms.gov/Medicare/Coding/
ICD10/C-and-M-Meeting-Materials. Any
inquiries related to the procedure code
topics scheduled for the September 12–
13, 2023, ICD–10 C&M Committee
meeting that are under consideration for
E:\FR\FM\31JYN1.SGM
31JYN1
]]>Agencies
[Federal Register Volume 88, Number 145 (Monday, July 31, 2023)]
[Notices]
[Pages 49464-49465]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-16102]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Solicitation of Nominations for Appointment to CDC's Advisory
Committee to the Director Data and Surveillance Workgroup
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The Centers for Disease Control and Prevention (CDC), within
the Department of Health and Human Services (HHS), is seeking
nominations for membership on the Advisory Committee to the Director
Data and Surveillance Workgroup (DSW). The DSW consists of
approximately 15 members who are experts in fields associated with
public health science and practice; policy development, analysis, and
implementation; and surveillance and informatics.
DATES: Nominations for membership on the DSW must be received no later
than August 30, 2023. Late nominations will not be considered for
membership.
ADDRESSES: All nominations (cover letters and curriculum vitae) should
be emailed to [email protected] with the subject line: ``Nomination for
CDC ACD DSW Workgroup.''
FOR FURTHER INFORMATION CONTACT: Agnes Warner, MPA, Office of Public
Health Data, Surveillance, and Technology, Centers for Disease Control
and Prevention, 1600 Clifton Road NE, Mailstop H21-10, Atlanta, Georgia
30329-4027. Telephone: (404) 639-3372; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The purpose of the Advisory Committee to the Director,
Centers for Disease Control and Prevention (ACD, CDC) is to (1) make
recommendations to the Director regarding ways to prioritize the
activities of the agency in alignment with the CDC Strategic Plan
required under section 305(c); H.R. 2617-1252; (2) advise on ways to
achieve or improve performance metrics in relation to the CDC Strategic
Plan, and other relevant metrics, as appropriate; (3) provide advice
and recommendations on the development of the Strategic Plan, and any
subsequent updates, as appropriate; (4) advise on grants, cooperative
agreements, contracts, or other transactions, as applicable; (5)
provide other advice to the Director, as requested, to fulfill duties
under sections 301 and 311; and (6) appoint subcommittees. The ACD, CDC
consists of up to 15 non-federal members, including the Chair,
knowledgeable in areas pertinent to the CDC mission, such as health
policy, public health, global health, preparedness, preventive
medicine, the faith-based and community-based sector, and allied
fields.
Purpose: The purpose of the ACD, CDC Data and Surveillance
Workgroup (DSW) is to provide input to the Committee on agency-wide
activities related to the scope and implementation of CDC's data
modernization strategy across the agency, ultimately playing a key role
in the agency's work with public health, healthcare, and academic and
private sector partners and with the promotion of equity. The DSW
membership consists of approximately 15 members. It is co-chaired by
two current ACD, CDC Special Government Employees. The DSW co-chairs
will present their findings, observations, and work products at one or
more ACD, CDC meetings for discussion, deliberation, and decisions
(final recommendations to CDC).
Nomination Criteria: DSW members will serve terms ranging from six
months to one year and be required to attend DSW meetings approximately
1-2 times per month (virtually or in person), and contribute time in
between meetings for research, consultation, discussion, and writing
assignments.
Nominations are being sought for individuals who have the expertise
and qualifications necessary to contribute to the accomplishments of
the committee's/workgroup's objectives. Nominees will be selected based
on expertise in the fields of public health science and practice;
public health preparedness and response; public health policy
development, analysis, and implementation; public health surveillance
and informatics; artificial intelligence; data analysis, data science,
and forecasting; health information technology; and healthcare delivery
from jurisdictional government agencies, non-government organizations,
academia, and the private sector. To ensure a diverse workgroup
composition, nominees with front line and field experience at the
local, state, tribal, and territorial levels are encouraged to apply.
This includes nominees with experience working for, and with,
community-based organizations and other non-profit organizations.
Federal employees will not be considered for membership. Selection of
members is based on candidates' qualifications to contribute to the
accomplishment of the DSW's objectives.
HHS policy stipulates that membership be balanced in terms of
points of view represented and the workgroup's function. Appointments
shall be made without discrimination based on age, race, ethnicity,
gender, sexual orientation, gender identity, HIV status, disability,
and cultural, religious, or socioeconomic status. Nominees must be U.S.
citizens. Current participation on federal workgroups or prior
experience serving on a federal advisory committee does not disqualify
a candidate; however, HHS policy is to avoid excessive individual
service on advisory committees and multiple committee memberships.
Interested candidates should submit the following items:
[ssquf] A one-half to one-page cover letter that includes your
understanding of, and commitment to, the time and work necessary; one
to two sentences on your background and experience; and one to two
sentences on the skills/perspective you would bring to the DSW.
[ssquf] Current curriculum vitae which highlights the experience
and work history being sought relevant to the criteria set forth above,
including complete contact information (telephone numbers, mailing
address, email address).
[[Page 49465]]
Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-16102 Filed 7-28-23; 8:45 am]
BILLING CODE 4163-18-P
